US FDA Staff Says TheraTech Inc. Drug Works But Problem Seen

May 25, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters -- A proposed drug from Theratechnologies Inc reduced abdominal fat in HIV patients, but the effects did not last when patients stopped treatment, U.S. reviewers said in documents released on Tuesday.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

Food and Drug Administration (FDA)